Playlist

Moscow to Host Large-Scale Days of Turkmen Culture Festival

01 Jun. 16:47

Source

In early June, Moscow will become the center of a major bilateral cultural exchange designed to showcase the vibrant heritage of Turkmenistan to the Russian public. The multi-day cultural forum is jointly organized by the Ministries of Culture of both nations. The event is actively supported by the Embassy of Turkmenistan in the Russian Federation and the federal state cultural agency "Rosconcert."

The artistic program features high-profile performances by leading national ensembles and vocalists at prestigious municipal venues. The inaugural concert is scheduled to take place at the Moscow State Academic Theater "Russkaya Pesnya," showcasing classical folk orchestrations. A subsequent major performance and closing ceremony will be hosted on the stage of the Moscow Theater "Et Cetera."

In addition to theatrical performances, the intercultural exchange will feature extensive art and historical exhibitions. Curated spaces will display unique specimens of Turkmen fine arts, traditional tapestry, and intricate decorative crafts. Visitors will have a rare opportunity to explore authentic customs, national costumes, and structural elements of ancient regional craftsmanship.

The organizing committee stated that all scheduled events are aimed at promoting cross-border mutual understanding, meaning public admission to all concert halls and galleries is entirely free of charge. To manage venue capacities effectively, a mandatory digital pre-registration system has been established for attendees. The cultural showcase marks a key milestone in reinforcing institutional humanitarian ties.

















US Scientists Develop Drug That Mimics Exercise Effects

Today in 10:05

Source

American researchers have initiated trials for a new pharmaceutical compound designated as ENV-308, designed to replicate the physiological effects of intensive physical training. Formulated in tablet form, the medication aims to trigger the body's metabolic responses similar to those experienced during exercise.

Scientists at Enveda utilized the Lac-Phe molecule as the core component for this development. Naturally produced by the body during vigorous exertion, this molecule transmits signals to the brain that suppress appetite and signal satiety.

Preclinical trials conducted on animal models demonstrated significant positive results. The tablets effectively reduced hunger levels and facilitated weight loss while entirely preserving existing muscle mass.

Researchers have successfully completed the first phase of clinical trials, confirming the safety of the drug for human use. Future studies will focus on evaluating the compound's impact on metabolism and exploring its potential combination with established therapeutics such as Ozempic.